(Q32060480)

6 July 2017

1 reference

title

Clinical experience with itraconazole in systemic fungal infections (English)

1 reference

6 July 2017

Boogaerts M

1

1 reference

6 July 2017

Maertens J

series ordinal

2

1 reference

6 July 2017

publication date

1 January 2001

1 reference

6 July 2017

1 reference

6 July 2017

volume

61 Suppl 1

1 reference

6 July 2017

page(s)

39-47

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200161001-00004

6 July 2017

exact match

0 references

cites work

Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study

1 reference

12 December 2020

Coccidioidomycosis in liver transplant patients

1 reference

12 December 2020

Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature

1 reference

12 December 2020

Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria.

1 reference

12 December 2020

Endemic mycoses: a treatment update

1 reference

12 December 2020

Treatment of paracoccidioidomycosis with itraconazole

1 reference

12 December 2020

Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders.

1 reference

12 December 2020

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units

1 reference

12 December 2020

Itraconazole cyclodextrin solution--effective treatment for HIV-related candidosis unresponsive to other azole therapy

1 reference

12 December 2020

Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients

1 reference

12 December 2020

Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis

1 reference

12 December 2020

Food interaction and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers.

1 reference

12 December 2020

Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.

1 reference

12 December 2020

Treatment of neonatal Candida albicans septicemia with itraconazole

1 reference

12 December 2020

Evidence for a pharmacokinetic interaction between itraconazole and tacrolimus in organ transplant patients

1 reference

12 December 2020

Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.

1 reference

12 December 2020

Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia.

1 reference

12 December 2020

Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL.

1 reference

12 December 2020

Itraconazole in the treatment of aspergillosis: a study of 16 cases

1 reference

12 December 2020

Itraconazole and HIV protease inhibitors: an important interaction

1 reference

12 December 2020

Progress in fighting systemic fungal infections in haematological neoplasia.

1 reference

12 December 2020

Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation

1 reference

12 December 2020

Disseminated histoplasmosis after orthotopic liver transplantation

1 reference

12 December 2020

Oral and intravenous itraconazole for systemic fungal infections in neutropenic haematological patients: meeting report. London, United Kingdom, 20 June 1998

1 reference

12 December 2020

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group

1 reference

12 December 2020

In vitro studies with R 51,211 (itraconazole)

1 reference

12 December 2020

Itraconazole therapy for chronic coccidioidal meningitis

1 reference

12 December 2020

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche

1 reference

12 December 2020

Effect of food on the pharmacokinetics of a new hydroxypropyl-beta-cyclodextrin formulation of itraconazole.

1 reference

12 December 2020

Disseminated nosocomial candidiasis in a pediatric intensive care unit.

1 reference

12 December 2020

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

1 reference

12 December 2020

Treatment of cryptococcal meningitis in liver transplantation

1 reference

12 December 2020

Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels

1 reference

12 December 2020

Fungal infection and liposomal amphotericin B (AmBisome) therapy in liver transplantation: a 2 year review

1 reference

12 December 2020

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

1 reference

12 December 2020

Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations. Working party of the British Society for Antimicrobial Chemotherapy

1 reference

12 December 2020

Itraconazole therapy for disseminated candidiasis in a very low birthweight neonate

1 reference

12 December 2020

Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease.

1 reference

12 December 2020

Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis

1 reference

12 December 2020

The efficacy of itraconazole against systemic fungal infections in neutropenic patients: A randomised comparative study with amphotericin B

1 reference

12 December 2020

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology

1 reference

12 December 2020

Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.

1 reference

12 December 2020

Antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia

1 reference

12 December 2020

Interaction of cyclosporin and itraconazole

1 reference

12 December 2020

Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility

1 reference

12 December 2020

Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature.

1 reference

12 December 2020

Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies

1 reference

12 December 2020

Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients

1 reference

12 December 2020

Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism

1 reference

12 December 2020

Amphotericin B with and without itraconazole for invasive aspergillosis: A three-year retrospective study

1 reference

12 December 2020

Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group

1 reference

12 December 2020

Enhanced bioavailability of itraconazole in hydroxypropyl-beta-cyclodextrin solution versus capsules in healthy volunteers.

1 reference

12 December 2020

Itraconazole resistance in Aspergillus fumigatus

1 reference

12 December 2020

A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection

1 reference

12 December 2020

A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus

1 reference

12 December 2020

Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole

1 reference

12 December 2020

Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis

1 reference

12 December 2020

Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group

1 reference

12 December 2020

Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506)

1 reference

12 December 2020

A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis

1 reference

12 December 2020

Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis

1 reference

12 December 2020

Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients

1 reference

12 December 2020

Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations

1 reference

12 December 2020

Prophylaxis of fungal infections with itraconazole in immunocompromised cancer patients

1 reference

12 December 2020

10.2165/00003495-200161001-00004

Identifiers

DOI

0 references

Dimensions Publication ID

1038810288

0 references

1 reference